AAAAAA

   
Results: 1-8 |
Results: 8
AGE AND PLATELET COUNT - A SIMPLE INDEX FOR PREDICTING THE PRESENCE OF HISTOLOGICAL LESIONS IN PATIENTS WITH ANTIBODIES TO HEPATITIS-C VIRUS
Authors: POYNARD T BEDOSSA P BIOULACSAGE P CALLARD P CHEVALLIER M DEGOTT C DEUGNIER Y FABRE M REYNES M VOIGT JJ ZAFRANI ES METREAU JM VALLA D OPOLON P DHUMEAUX D CHAPUT JC CHARLOTTE F LEMONNIER C BABANY G AGOSTINI H
Citation: T. Poynard et al., AGE AND PLATELET COUNT - A SIMPLE INDEX FOR PREDICTING THE PRESENCE OF HISTOLOGICAL LESIONS IN PATIENTS WITH ANTIBODIES TO HEPATITIS-C VIRUS, Journal of viral hepatitis, 4(3), 1997, pp. 199-208
RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA-2B IN HEPATITIS-C VIRUS-RELATED CIRRHOSIS
Authors: VALLA D CHEVALLIER M PAYEN JL MARCELLIN P PARLIER D TREPO C COUZIGOU P DEGOS F BOUCHER E MIGUET J GAUTHIER A LEMONNIER C OPOLON P
Citation: D. Valla et al., RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA-2B IN HEPATITIS-C VIRUS-RELATED CIRRHOSIS, Hepatology, 26(4), 1997, pp. 1167-1167
SUSTAINED RESPONSE TO INTERFERON-ALFA 2B IS AFFECTED BY DOSE AND DURATION OF THERAPY - PRELIMINARY-RESULTS OF A FRENCH MULTICENTER RANDOMIZED TRIAL
Authors: OUZAN D DESMORAT H BOURLIERE M BALDINI E BOYER N FONTANGES T MATHIEUCHANDELIER C JACQUES JP BAESJOU S ROUHIER D LOUVET H HANSLIK B BEORCHIA S ANTONI M BRUNERIE M CORCOS D RICHARDMOLARD B PIERRUGUES R CAUCANAS J JOUANOLLE H DUMANOIR C LANGLOIS C LEMONNIER C KHIRI H BRICHETTI A HALFON P
Citation: D. Ouzan et al., SUSTAINED RESPONSE TO INTERFERON-ALFA 2B IS AFFECTED BY DOSE AND DURATION OF THERAPY - PRELIMINARY-RESULTS OF A FRENCH MULTICENTER RANDOMIZED TRIAL, Hepatology, 24(4), 1996, pp. 1727-1727
AN OPEN TRIAL OF INTERFERON-ALFA RECOMBINANT FOR HEPATITIS-C AFTER LIVER-TRANSPLANTATION - ANTIVIRAL EFFECTS AND RISK OF REJECTION
Authors: FERAY C SAMUEL D GIGOU M PARADIS V DAVID MF LEMONNIER C REYNES M BISMUTH H
Citation: C. Feray et al., AN OPEN TRIAL OF INTERFERON-ALFA RECOMBINANT FOR HEPATITIS-C AFTER LIVER-TRANSPLANTATION - ANTIVIRAL EFFECTS AND RISK OF REJECTION, Hepatology, 22(4), 1995, pp. 1084-1089
A COMPARISON OF 3 INTERFERON ALFA-2B REGIMENS FOR THE LONG-TERM TREATMENT OF CHRONIC NON-A, NON-B-HEPATITIS
Authors: POYNARD T BEDOSSA P CHEVALLIER M MATHURIN P LEMONNIER C TREPO C COUZIGOU P PAYEN JL SAJUS M COSTA JM VIDAUD M CHAPUT JC
Citation: T. Poynard et al., A COMPARISON OF 3 INTERFERON ALFA-2B REGIMENS FOR THE LONG-TERM TREATMENT OF CHRONIC NON-A, NON-B-HEPATITIS, The New England journal of medicine, 332(22), 1995, pp. 1457-1462
LACK OF BENEFIT OF ESCALATING DOSAGE OF INTERFERON-ALFA IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: MARCELLIN P POUTEAU M MARTINOTPEIGNOUX M DEGOS F DUCHATELLE V BOYER N LEMONNIER C DEGOTT C ERLINGER S BENHAMOU JP
Citation: P. Marcellin et al., LACK OF BENEFIT OF ESCALATING DOSAGE OF INTERFERON-ALFA IN PATIENTS WITH CHRONIC HEPATITIS-C, Gastroenterology, 109(1), 1995, pp. 156-165
COMPARATIVE EFFICACY OF INTERFERON-ALFA IN CIRRHOTIC AND NONCIRRHOTICPATIENTS WITH NON-A, NON-B, C HEPATITIS
Authors: JOUET P ROUDOTTHORAVAL F DHUMEAUX D METREAU JM CALMUS Y POUPON R JOUANOLLE H MIGUET JP BRECHOT C PAYEN JL CALES P TRAN A BEAUGRAND M CAPRON JP ZARSKI JP DOFFOEL M PARIENTE EA LEMONNIER C
Citation: P. Jouet et al., COMPARATIVE EFFICACY OF INTERFERON-ALFA IN CIRRHOTIC AND NONCIRRHOTICPATIENTS WITH NON-A, NON-B, C HEPATITIS, Gastroenterology, 106(3), 1994, pp. 686-690
IMPROVEMENT OF HISTOLOGICAL LESIONS BY 18 MONTHS THERAPY WITH ALPHA-2B INTERFERON (IFN 2B) IN PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED CLINICAL-TRIAL
Authors: POYNARD T BEDOSSA P CHEVALLIER M MATHURIN P LEMONNIER C
Citation: T. Poynard et al., IMPROVEMENT OF HISTOLOGICAL LESIONS BY 18 MONTHS THERAPY WITH ALPHA-2B INTERFERON (IFN 2B) IN PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED CLINICAL-TRIAL, Hepatology, 18(4), 1993, pp. 10000090-10000090
Risultati: 1-8 |